Predictors of rebleeding and in-hospital mortality in patients with nonvariceal upper digestive bleeding

Table 8 Clinical and endoscopic features of the study population: Association with deaths

Parameter	Survivors (no. pts, %)	Deaths (no. pts, %)	Total no. patients, %	Total (% out of entire batch)	P value
Lesion	1453 (91.90)	128 (8.10)	1581 (100)	100	0.001
Rockall score	1442 (92.61)	115 (7.39)	1557 (100)	100	< 0.001
Simple therapy	160 (91.95)	14 (8.05)	174 (100)	11.01	0.069
Combined therapy	355 (94.66)	20 (5.34)	375 (100)	23.72	0.209
SBP < 100 mmHg	216 (75)	72 (25)	288 (100)	18.22	< 0.001
Pulse > 100 beats per minute	392 (84.67)	71 (15.53)	463 (100)	29.32	< 0.001
Rebleeding	109 (88.62)	14 (11.38)	123 (100)	7.78	0.164
Hospitalization length	1449 (91.94)	127 (8.06)	1576 (100)	100	< 0.001
No. blood units	1452 (91.96)	127 (8.04)	1579 (100)	100	< 0.001
Aspirin	301 (95.56)	14 (4.44)	315 (100)	19.92	0.028
NSAIDs	237 (96.73)	8 (3.27)	245 (100)	15.50	0.003
Surgery	51 (100)	0.00 (0.00)	51 (100)	3.23	0.031
Cardiovascular comorbidities	895 (91.70)	81 (8.30)	976 (100)	61.73	0.707
Diabetes mellitus	268 (90.54)	28 (9.46)	296 (100)	18.72	0.340
Respiratory comorbidities	156 (75.73)	50 (24.27)	206 (100)	13.03	< 0.001
Renal comorbidities	285 (86.36)	45 (13.64)	330 (100)	20.87	< 0.001
Liver cirrhosis	115 (81.56)	26 (18.44)	141 (100)	8.92	< 0.001
Neoplasias	225 (87.89)	31 (12.11)	256 (100)	16.19	0.010
Neurologic comorbidities	193 (90.19)	21 (9.81)	214 (100)	13.54	0.322
Obesity	127 (94.78)	7 (5.22)	134 (100)	8.48	0.203
Sepsis	25 (53.19)	22 (46.81)	47 (100)	2.97	< 0.001
Acute pancreatitis	4 (50)	4 (50)	8 (100)	0.51	< 0.001
Acute abdomen	5 (83.33)	1 (16.67)	6 (100)	0.38	0.441

SBP: Systolic blood pressure; NSAIDs: Non-steroidal anti-inflammatory drugs.